Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Ascendis Pharma A/S
Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs.
IPO Date: July 11, 2008
Sector: Healthcare
Industry: Biotech
Market Cap: $10.57B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.71 | 1.93%
Avg Daily Range (30 D): $2.74 | 1.58%
Avg Daily Range (90 D): $3.27 | 2.02%
Institutional Daily Volume
Avg Daily Volume: .14M
Avg Daily Volume (30 D): .35M
Avg Daily Volume (90 D): .42M
Trade Size
Avg Trade Size (Sh.): 68
Avg Trade Size (Sh.) (30 D): 44
Avg Trade Size (Sh.) (90 D): 47
Institutional Trades
Total Inst.Trades: 3,648
Avg Inst. Trade: $3.41M
Avg Inst. Trade (30 D): $4.03M
Avg Inst. Trade (90 D): $3.87M
Avg Inst. Trade Volume: .03M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.96M
Avg Closing Trade (30 D): $3.73M
Avg Closing Trade (90 D): $3.6M
Avg Closing Volume: 23.98K
   
News
Feb 20, 2025 @ 2:39 PM
Why Is BioMarin Stock Trading Higher On Thursday?
Source: Vandana Singh
Nov 4, 2024 @ 6:34 PM
Wegovy Manufacturer Inks Multi-Million Deal For Mo...
Source: Vandana Singh
Sep 25, 2024 @ 7:50 PM
BioMarin Stands Firm on 2027 Revenue Target Amid A...
Source: Vandana Singh
Sep 22, 2024 @ 9:34 PM
Bausch & Lomb And Edgewise Therapeutics Are Among ...
Source: Lekha Gupta
Sep 20, 2024 @ 12:16 AM
Ascendis Pharma A/S Announces Pricing of Public Of...
Source: N/A